Andera Partners

Venture Capital Active France
Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
2
Rounds led
1
Rounds' value
$105.0M
total disclosed, rounds participated
Stages
—

Portfolio · 2

SoniVie
Pulmonary Hypertension Denervation Treatment
Led ★ 1 round $60.0M committed Latest: 2023-01
LogicBio Therapeutics
Gene Therapy for Genetic and Infectious Diseases
1 round $45.0M committed Latest: 2017-06

Investment activity

2 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences2

Q&A

What is Andera Partners' most recent exit?
Andera Partners most recently exited SoniVie in March 2025 through an acquisition by Boston Scientific for $400M.
What is Andera Partners' sector focus?
Andera Partners shows a concentration in the Health Tech & Life Sciences sector, with all of its recorded portfolio companies and exits falling within this area.
Which portfolio companies has Andera Partners invested in?
Andera Partners has invested in companies such as LogicBio Therapeutics and SoniVie.
What was a notable past exit for Andera Partners?
Andera Partners had a notable exit in October 2018 when LogicBio Therapeutics went public on NASDAQ with a valuation of $219.4M, raising $70M.
What is the typical investment range for Andera Partners?
Andera Partners typically invests in the range of $45M - $60M.
When was Andera Partners' most recent portfolio company added?
Andera Partners added a new portfolio company in January 2023.